Literature DB >> 17575320

Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.

Amr S Soliman1, An-Chi Lo, Mousumi Banerjee, Nabih El-Ghawalby, Hussein M Khaled, Sherif Bayoumi, Ibrahim A Seifeldin, Atef Abdel-Aziz, James L Abbruzzese, Joel K Greenson, Stanley R Hamilton.   

Abstract

BACKGROUND: Variations in genetic mutations in pancreatic carcinoma between different geographical regions have not been studied extensively, especially in developing countries where pancreatic cancer is relatively rare.
METHODS: We studied the molecular pathology of 54 pancreatic adenocarcinomas from Egyptian patients residing in a heavily polluted region of the eastern Nile River delta and compared the findings with 45 tumors from patients residing in low-pollution regions.
RESULTS: Rates of K-ras mutation in codon 12 and of p53 mutation in exons 5-8 were higher in tumors of patients from the high-pollution region as compared with the low-pollution regions (61.5 versus 34.2%, respectively, for K-ras, P = 0.01; 25.9 versus 11.6%, respectively, for p53, P = 0.08). There were also distinct differences in the specific types of K-ras and p53 mutations between the two regions. The ratio of G-to-T k-ras transversion mutation (codon 12) relative to wild-type was significantly higher in tumors from the high-pollution region (0.90) than tumors from the non-pollution site (0.28) (P = 0.03). Relative to tumors with wild-type, the ratio of p53 mutations in exons 5, 7 or 8 to wild-type in tumors from the high-pollution region was significantly higher than the ratio from the non-pollution site (0.28 versus 0.03, P = 0.01). Logistic regression showed that G-to-T transversion mutation in K-ras was predicted by the region of residence of the patients.
CONCLUSIONS: Our study reveals that there are differences in the frequencies and types of K-ras and p53 mutations found in pancreatic adenocarcinomas of patients in high-pollution and low-pollution regions in Egypt and suggests that environmental factors may explain these differences. We speculate that gene-environment interactions in pancreatic carcinogenesis also occur in other populations.

Entities:  

Mesh:

Year:  2007        PMID: 17575320     DOI: 10.1093/carcin/bgm138

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  5 in total

1.  Cancer education and research in international settings: challenges and opportunities.

Authors:  Amr S Soliman
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

2.  Differences in Molecular Pathologic Characteristics of Pancreatic Adenocarcinoma between Egyptian and Moroccan Patients.

Authors:  Sara Robinson; Amr Soliman; Mehdi Karkouri; Hoda Gad Omer; Joel F Greenson
Journal:  Middle East J Cancer       Date:  2010-01

Review 3.  Inflammatory breast cancer: New factors contribute to disease etiology: A review.

Authors:  Mona M Mohamed; Diaa Al-Raawi; Salwa F Sabet; Mohamed El-Shinawi
Journal:  J Adv Res       Date:  2013-06-14       Impact factor: 10.479

4.  Regional Variation of Pancreatic Cancer Incidence in the Nile Delta Region of Egypt over a Twelve-Year Period.

Authors:  Christina Baum; Amr S Soliman; Heidi E Brown; Ibrahim A Seifeldin; Mohamed Ramadan; Breanne Lott; An Nguyen; Ahmed El-Ghawalby; Ahmed Hablas
Journal:  J Cancer Epidemiol       Date:  2020-07-14

5.  Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG).

Authors:  George Zarkavelis; Vassiliki Kotoula; Georgia-Angeliki Kolliou; Kyriaki Papadopoulou; Ioannis Tikas; Vasilios Karavasilis; Epaminontas Samantas; Christos Dervenis; Ioannis Efstratiou; Irene Nicolaou; Dimitra Apessou; Georgia Kafiri; Triantafyllia Koletsa; Iliada Bompolaki; Grigorios Rallis; Anna Batistatou; George Glantzounis; Dimitrios Pectasides; George Fountzilas; George Pentheroudakis
Journal:  ESMO Open       Date:  2019-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.